Clinical Trial Update: β-Cell Function in Schizophrenic Subjects on Atypical Antipsychotic drugS

View source ↗

Summary

A clinical trial evaluating beta-cell function in subjects with schizophrenia treated with atypical antipsychotic drugs has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Conditions: Schizophrenia | Status: COMPLETED